Attached files

file filename
8-K/A - FORM 8-K (AMENDMENT NO. 1) - ACETO CORPt69971_8ka.htm
EX-23.2 - EXHIBIT 23.2 - ACETO CORPex23-2.htm
EX-99.1 - EXHIBIT 99.1 - ACETO CORPex99-1.htm
EX-23.1 - EXHIBIT 23.1 - ACETO CORPex23-1.htm

Aceto Corporation  Exhibit 99.2
 
UNAUDITED PRO FORMA FINANCIAL INFORMATION (in thousands)

 On December 31, 2010, Aceto Corporation (“Aceto” or the “Company”) acquired certain assets of Rising Pharmaceuticals, Inc. (“Rising”), a New Jersey based company that markets and distributes generic prescription and over the counter pharmaceutical products to leading wholesalers, chain drug stores, distributors, mass market merchandisers and others under its own label, throughout the United States. The purchase price was approximately $73,317 which was comprised of the issuance of 1,000 shares of Aceto common stock, valued at $9,000, cash payment of approximately $58,817 and approximately $5,500 liability due to Rising to satisfy bulk sales tax obligation. The purchase agreement also calls for $8,000 of deferred consideration to be paid by Aceto over a four year period. In addition, the agreement provides for the payment of additional contingent consideration equal to one-half of the three year cumulative Rising earnings before interest, taxes, deprecation and amortization in excess of $32,100, up to a maximum of $6,000. As of December 31, 2010, the Company had accrued $850 related to this contingent consideration.

The following unaudited pro forma combined financial statements reflect the acquisition of certain assets of Rising using the purchase method of accounting. The acquisition has been accounted for in conformity with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 805, Business Combinations (“ASC 805”). The pro forma adjustments are based upon available information and assumptions that we believe are reasonable. The pro forma adjustments are preliminary and have been prepared to illustrate the estimated effect of the acquisition. Differences between these preliminary estimates and the final acquisition accounting will occur and these differences could have a material impact on the accompanying unaudited pro forma combined financial statements and the combined companies’ future results of operations and financial position. The unaudited pro forma combined financial statements do not purport to be indicative of the operating results or financial position that would have been achieved had the acquisition taken place on the date indicated or the results that may be obtained in the future.

The unaudited pro forma combined balance sheet as of September 30, 2010 is presented as if our acquisition of certain assets of Rising had occurred on September 30, 2010.
 
The unaudited pro forma combined consolidated statements of income for the year ended June 30, 2010 and the three months ended September 30, 2010 illustrate the effect of the Rising acquisition as if it had occurred on July 1, 2009. The unaudited pro forma combined consolidated statement of income for the year ended June 30, 2010 combines the historical audited statement of income of Aceto for the year ended June 30, 2010 and Rising’s historical unaudited statement of income for the twelve months ended June 30, 2010. Rising’s fiscal year ended on December 31 and thus, the twelve month period was compiled by combining each quarterly statement of income for each period from July 1, 2009 to June 30, 2010. The unaudited pro forma combined consolidated statement of income for the three months ended September 30, 2010 combines the historical unaudited statement of income of both Aceto and Rising for the three months ended September 30, 2010. The historical consolidated financial information has been adjusted to give effect to pro forma events that are (i) directly attributable to the acquisition, (ii) factually supportable, and (iii) with respect to the statements of income, expected to have a continuing impact on the combined results of the companies. These unaudited pro forma condensed combined financial statements are prepared by management for informational purposes only in accordance with Article 11 of Securities and Exchange Commission Regulation S-X and are not necessarily indicative of future results or of actual results that would have been achieved had the acquisition been consummated as of the dates presented, and should not be taken as representative of future consolidated operating results of Aceto. The unaudited pro forma combined financial statements do not reflect any operating efficiencies and/or cost savings that we may achieve, or any additional expenses or costs of integration that we may incur, with respect to the combined companies as such adjustments are not factually supportable at this point in time. The assumptions used to prepare the pro forma financial information are contained in the notes to the unaudited pro forma combined financial statements, and such assumptions should be reviewed in their entirety.

The unaudited pro forma combined financial statements have been developed from and should be read in conjunction with (i) the historical audited consolidated financial statements for the year ended June 30, 2010 and notes thereto of Aceto contained in its Annual Report on Form 10-K , (ii) the historical unaudited consolidated financial statements and notes thereto of Aceto contained in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 and (iii) historical audited financial statements and notes thereto of Rising, included in exhibit 99.1 of this Current Report on Form 8-K.
 
 
 

 
 
ACETO CORPORATION
Unaudited Pro Forma Combined Balance Sheet
September 30, 2010
   
 
Aceto
September 30,
2010
Historical
   
 
Rising September 30,
2010
Historical
 
 
 
 
 
Pro Forma
Adjustments
     
 
 
 
Pro Forma Combined
 
   
 
   
 
             
ASSETS
                       
Current assets:
                       
Cash and cash equivalents
  $ 40,113     $ 8,926   $ (8,817 )
(A)
  $ 40,222  
Investments
    402       -     -         402  
Trade receivables, less allowance for doubtful accounts
    58,354       10,669     -         69,023  
Other receivables
    13,087       -     -         13,087  
Inventory
    77,050       2,775     258  
(B)
    80,083  
Prepaid expenses and other current assets
    2,155       1,052     66  
(C)
    3,273  
Deferred income tax asset, net
    1,750       -     -         1,750  
Total current assets
    192,911       23,422     (8,493 )       207,840  
                                 
Property and equipment, net
    7,183       600     -         7,783  
Property held for sale
    3,752       -     -         3,752  
Goodwill
    1,830       821     30,942  
(D)
    33,593  
Intangible assets, net
    11,834       -     43,200  
(E)
    55,034  
Deferred income tax asset, net
    2,337       -     -         2,337  
Other assets
    9,814       30     -         9,844  
                                 
TOTAL ASSETS
  $ 229,661     $ 24,873   $ 65,649       $ 320,183  
                                 
LIABILITIES AND SHAREHOLDERS’ EQUITY
                               
Current liabilities:
                               
Accounts payable
  $ 30,135     $ 976     -       $ 31,111  
Short-term bank loans
    5,000       -     6,000  
(A)
    11,000  
Accrued expenses
    28,306       5,900     647  
(F)
    54,499  
                    2,600  
(G)
       
                    11,546  
(H)
       
                    5,500  
(I)
       
Deferred income tax liability
    897       -     -         897  
Total current liabilities
    64,338       6,876     26,293         97,507  
                                 
Long-term bank loans
    550       -     44,000  
(A)
    44,550  
Long-term liabilities
    9,310       -     7,600  
(J)
    16,910  
Environmental remediation liability
    7,539       -               7,539  
Deferred income tax liability
    44       -     -         44  
Total liabilities
    81,781       6,876     77,893         166,550  
                                 
                                 
Shareholders’ equity:
                               
    Common stock
    256       174     10  
(K)
    266  
                    (174 )
(L)
       
    Capital in excess of par value
    53,776       -     8,990  
(K)
    62,766  
 Retained earnings
    89,755       18,570     (647 )
(F)
    86,508  
                    (2,600 )
(G)
       
                    (18,570 )
(L)
       
 Treasury
    (1,926 )     (747 )   747  
(L)
    (1,926 )
 Accumulated other comprehensive income
     6,019        -      -          6,019  
 Total shareholders’ equity
    147,880       17,997     (12,244 )       153,633  
                                 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  $ 229,661     $ 24,873   $ 65,649       $ 320,183  
 
See the accompanying notes to the Pro Forma Combined Financial Statements
 
 
2

 
 
ACETO CORPORATION
   
Unaudited Pro Forma Combined Statement of Income
   
For The Year Ended June 30, 2010
   
(In thousands, except per share amounts)
   
                         
   
Aceto
for the
year ended
   
Rising
             
       
for the
             
       
twelve months
ended
             
   
June 30, 2010
   
June 30, 2010
   
Pro Forma
     
Pro Forma
   
Historical
   
Historical
   
Adjustments
     
Combined
                         
Net sales
  $ 346,631     $ 48,462             $ 395,093  
Cost of sales
    292,476        27,077               319,553  
      Gross profit
    54,155       21,385       -         75,540  
                                     
Selling, general and administrative expenses
    44,717       8,457       4,321  
(M)
    57,495  
                                     
Operating income
    9,438       12,928       (4,321 )       18,045  
                                     
Other income (expense):
                                   
       Interest expense
    (230 )     (6 )               (236 )
       Interest and other income (expense), net
    995       31       (1,750 )
(N)
         
                      (522
(O)
    (1,246 )
      765       25       (2,272       (1,482 )
                                     
Income before income taxes
    10,203       12,953       (6,593       16,563  
                                     
Income tax provision
    3,622       9       2,480  
(P)
    6,111  
Net income
  $ 6,581     $ 12,944     $ (9,073     $ 10,452  
                                     
                                     
Net income per common share
  $ 0.26                       $ 0.40  
Diluted net income per common share
  $ 0.26                       $ 0.40  
                                     
Weighted average shares outstanding:
                                   
                                     
      Basic
    24,979               1,000  
( K)
    25,979  
                                   
      Diluted
    25,224               1,000  
( K)
    26,224  
 
See the accompanying notes to the Pro Forma Combined Financial Statements
 
 
3

 
 
ACETO CORPORATION
   
Unaudited Pro Forma Combined Statement of Income
   
For The Three Months Ended September 30, 2010
   
(In thousands, except per share amounts)
   
                       
   
Aceto
   
Rising
           
   
for the
   
for the
           
   
three months
ended
   
three months
ended
           
   
September 
30, 2010
   
September 
30, 2010
   
Pro Forma
   
Pro Forma
   
Historical
   
Historical
   
Adjustments
   
Combined
                       
Net sales
  $ 87,660     $ 12,382           $ 100,042  
Cost of sales
     74,373        5,540             79,913  
      Gross profit
    13,287       6,842       -       20,129  
                                   
Selling, general and administrative expenses
    9,597       2,779       1,080
(M)
    13,456  
                                   
Operating income
    3,690       4,063       (1,080 )     6,673  
                                   
Other income (expense):
                                 
       Interest expense
    (111 )     6               (105 )
       Interest and other income (expense), net
    671       3       (438)
(N)
         
                      (65)
(O)
    171  
      560       9       (503 )     66  
                                   
Income before income taxes
    4,250       4,072       (1,583 )     6,739  
                                   
Income tax provision
    1,453       17       971
(P)
    2,441  
Net income
  $ 2,797     $ 4,055     $ (2,554 )   $ 4,298  
                                   
                                   
Net income per common share
  $ 0.11                     $ 0.16  
Diluted net income per common share
  $ 0.11                     $ 0.16  
                                   
Weighted average shares outstanding:
                                 
                                   
      Basic
    25,329               1,000
( K)
    26,329  
                                 
      Diluted
    25,506               1,000
( K)
    26,506  
 
See the accompanying notes to the Pro Forma Combined Financial Statements
 
 
4

 

ACETO CORPORATION
Notes to Unaudited Pro Forma Combined Financial Statements
(In thousands, except per share amounts)


1.           Background and Basis of Pro Forma Presentation

On December 31, 2010, Aceto Corporation (“Aceto” or the “Company”) acquired certain assets of Rising Pharmaceuticals, Inc. (“Rising”),  a New Jersey based company that markets and distributes generic prescription and over the counter pharmaceutical products to leading wholesalers, chain drug stores, distributors, mass market merchandisers and others under its own label, throughout the United States.

The unaudited pro forma combined financial information was prepared based on the historical financial statements of Aceto and Rising.

Our acquisition has been accounted for in conformity with ASC 805 and uses the fair value concepts defined in Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820-10”). ASC 805 requires, among other things, that most assets acquired and liabilities assumed in an acquisition be recognized at their fair values as of the acquisition date and requires that fair value be measured based on the principles in ASC 820-10. ASC 820-10 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 also requires that a fair value measurement reflect the assumptions market participants would use in pricing an asset or liability based on the best information available.


2.           Purchase Price Allocation

The acquisition is accounted for using the acquisition method of accounting. The total estimated purchase price is comprised of the following:

Cash paid at initial closing
  $ 58,817  
Common stock issued
    9,000  
Bulk sales tax obligation
    5,500  
Estimated present value of deferred consideration
    6,750  
Estimated present value of additional contingent consideration
     850  
    $ 80,917  
         
 
 
5

 

The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed on the closing date of December 31, 2010 as if the acquisition had occurred on September 30, 2010.

Cash and cash equivalents
  $ 8,926  
Trade receivables
    10,669  
Inventory
    3,033  
Prepaid expenses and other current assets
    1,118  
Property and equipment, net
    600  
Goodwill
    31,763  
Intangible assets
    43,200  
Other assets
     30  
  Total assets acquired
    99,339  
         
Accounts payable
    976  
Accrued expenses
    17,446  
         
Net assets acquired
  $ 80,917  
         



3.           Pro Forma Financial Statement Adjustments

The following pro forma adjustments are included in the Company’s unaudited pro forma combined financial statements:

 
A.
To reflect $58,817 of cash paid in connection with the acquisition of Rising, offset by the incurrence of $50,000 of bank borrowings used to finance the acquisition.

 
B.
Adjustment to record a $258 step-up in the fair value of inventory.

 
C.
To reflect purchase of continuum insurance policy.

 
D.
To eliminate Rising’s historical goodwill of $821 and record the preliminary estimate of goodwill for our acquisition of Rising of $31,763.

 
E.
To record the preliminary estimate of the fair value of intangible assets for our acquisition of Rising. The amortizable intangible assets acquired are comprised of the following:  approximately $32,500 of product rights, amortizable over a period of seven to fourteen years; approximately $5,100 of license agreements, amortizable over six years; approximately $3,900 of customer relationships, amortizable over eleven years; and approximately $1,700 of trademarks, amortizable over a period of four years.

 
F.
To reflect after tax impact of non-recurring acquisition-related transaction costs.

 
G.
To reflect tax charge related to the repatriation of earnings from certain foreign subsidiaries to assist with the funding of the acquisition.

 
H.
To reflect working capital adjustment calculated in accordance with the asset purchase agreement.

 
I.
To reflect approximate $5,500 liability due to Rising to satisfy bulk sales tax obligation.
 
 
6

 
 
 
J.
To reflect the fair value of deferred consideration of $6,750 to be paid by Aceto over a four year period and the fair value of additional contingent consideration of $850 equal to one-half of the three year cumulative Rising earnings before interest, taxes, deprecation and amortization in excess of $32,100, up to a maximum of $6,000.

 
K.
To reflect 1,000 shares of Aceto common stock issued in connection with the acquisition of certain assets of Rising, valued at $9.00, the closing price of Aceto stock on the closing date.

 
L.
To eliminate Rising's historical shareholders' equity.

 
M.
Adjustment to record the amortization expense related to the amortizable intangible assets acquired.

 
N.
To reflect increase in interest expense associated with bank borrowings to fund the acquisition.  On December 31, 2010, we borrowed $10,000 of Revolving Loans and a Term Loan of $40,000. Both loans were utilized by us to partially finance payment of the purchase price for the Rising acquisition. The interest rate on both loans is at an Alternate Base Rate or 3.5% at December 31, 2010. Aceto may repay the Revolving Loan during the period ending December 31, 2015. The Term Loan is payable as to principal in twenty (20) consecutive quarterly installments, commencing March 31, 2011 and on each June 30, September 30 and December 31st thereafter.

 
O.
To reflect interest expense associated with the discount of the deferred consideration and the contingent consideration.

 
P.
Adjustment to record an income tax provision for Rising and pro forma adjustments using a 39% tax rate. Prior to the acquisition, Rising was an S Corporation and was not taxed at the Corporation level.


The pro forma adjustments included in the income statements do not give effect to the impact on gross profit of the adjustment to increase inventory by approximately $258 to its estimated fair value and the impact of non-recurring acquisition-related transaction costs of approximately $1,060. The pro forma adjustments included in the income statements also do not give effect to the impact of the $2,600 tax charge related to the repatriation of earnings from certain foreign subsidiaries to assist with the funding of the acquisition.
 
7